Borregaard ASA (LON:0QB7)

Market Cap	1.45B
Revenue (ttm)	560.90M
Net Income (ttm)	63.85M
Shares Out	n/a
EPS (ttm)	0.64
PE Ratio	22.67
Forward PE	19.48
Dividend	0.30 (0.15%)
Ex-Dividend Date	Apr 11, 2025

Volume	13,334
Average Volume	9,807
Open	200.20
Previous Close	200.78
Day's Range	198.00 - 199.90
52-Week Range	156.05 - 209.00
Beta	0.72
RSI	52.65
Earnings Date	Jul 16, 2025

About Bally's

Borregaard ASA engages in the development, production, and marketing of specialized biochemicals and biomaterials in Norway, rest of Europe, Asia, the United States, and internationally. It operates in three segments: BioSolutions, BioMaterials, and Fine Chemicals. The company develops, produces, and sells biopolymers and biovanillin for agrochemicals, batteries, industrial binders, and construction, as well as to flavour and fragrance companies, and food and beverage industry. It also develops, produces, and sells speciality cellulose for use ...

• Industry: Chemicals and Allied Products
• Founded: 2012
• Employees: 1,174
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0QB7

Financial Performance

In 2024, Borregaard ASA's revenue was 7.62 billion, an increase of 6.80% compared to the previous year's 7.13 billion. Earnings were 823.00 million, a decrease of -5.40%.